Chugai Pharmaceutical Co., Ltd. (TYO:4519)
Japan · Delayed Price · Currency is JPY 6,948.00
-101.00 (-1.43%)
Nov 4, 2025, 3:30 PM JST
Chugai Pharmaceutical Revenue
Chugai Pharmaceutical had revenue of 333.18B JPY in the quarter ending September 30, 2025, with 5.54% growth. This brings the company's revenue in the last twelve months to 1.21T, up 6.25% year-over-year. In the year 2024, Chugai Pharmaceutical had annual revenue of 1.17T with 5.33% growth.
Revenue (ttm)
1.21T
Revenue Growth
+6.25%
P/S Ratio
9.42
Revenue / Employee
241.49M
Employees
5,026
Market Cap
11.43T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.17T | 59.24B | 5.33% |
| Dec 31, 2023 | 1.11T | -148.58B | -11.79% |
| Dec 31, 2022 | 1.26T | 260.19B | 26.02% |
| Dec 31, 2021 | 999.76B | 212.81B | 27.04% |
| Dec 31, 2020 | 786.95B | 100.76B | 14.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Terumo | 1.04T |
| Olympus | 969.02B |
| HOYA Corporation | 892.50B |
| Eisai | 803.02B |
Chugai Pharmaceutical News
- 11 days ago - Chugai Pharmaceutical 9-month Net Income Rises - Nasdaq
- 15 days ago - Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Benzinga
- 18 days ago - Rani Therapeutics surges on Chugai licensing deal, private placement - Seeking Alpha
- 18 days ago - Rani Teams Up With Chugai To Revolutionize Oral Drug Delivery For Rare Diseases - Benzinga
- 3 months ago - Chugai Pharmaceutical Co., Ltd. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - Chugai Pharmaceutical Co., Ltd. (CHGCF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Chugai Pharmaceutical reports Q2 results - Seeking Alpha
- 5 months ago - Biotech behind Eli Lilly obesity pill aims for new standard of care - Financial Times